Decreasing Continuous Positive Airway Pressure Failure in Preterm Infants

医学 持续气道正压 胎龄 队列 动脉导管 机械通风 支气管肺发育不良 新生儿重症监护室 呼吸衰竭 儿科 麻醉 内科学 怀孕 遗传学 生物 阻塞性睡眠呼吸暂停
作者
Venkatakrishna Kakkilaya,Heather M. Weydig,William Smithhart,Shelly D. Renfro,Kristi M. Garcia,Cari Brown,Henry He,Sheron Wagner,Glenn C. Metoyer,L. Steven Brown,Vishal Kapadia,Rashmin C. Savani,Mambarambath A. Jaleel
出处
期刊:Pediatrics [American Academy of Pediatrics]
卷期号:148 (4) 被引量:7
标识
DOI:10.1542/peds.2020-014191
摘要

Many preterm infants stabilized on continuous positive airway pressure (CPAP) at birth require mechanical ventilation (MV) during the first 72 hours of life, which is defined as CPAP failure. Our objective was to decrease CPAP failure in infants ≤29 weeks' gestational age (GA).A quality improvement bundle named OPTISURF was implemented for infants ≤29 weeks' GA admitted on CPAP, consisting of stepwise escalation of CPAP and less invasive surfactant administration guided by fractional inspired oxygen concentration ≥0.3. The CPAP failure rate was tracked by using control charts. We compared practice and outcomes of a pre-OPTISURF cohort (January 2017 to September 2018) to a post-OPTISURF cohort (October 2018 to December 2019).Of the 216 infants ≤29 weeks' GA admitted to NICU on CPAP, 125 infants belonged to the pre-OPTISURF cohort (OSC) and 91 to the post-OSC. Compared with the pre-OSC, a higher proportion of infants in the post-OSC received CPAP 7 cm H2O within 4 hours of life (7% vs 32%; P < .01). The post-OSC also had lower rates of CPAP failure (54% vs 11%; P < .01), pneumothoraces (8% vs 1%; P < .03), need for MV (58% vs 31%; P < .01), and patent ductus arteriosus treatment (21% vs 9%; P = .02). Additionally, in a subgroup analysis, CPAP failure was lower in the post-OSC among infants 23 to 26 weeks (79% vs 27%; P < .01) and 27 to 29 weeks' GA (46% vs 3%; P < .01).Implementation of a quality improvement bundle including CPAP optimization and less invasive surfactant administration decreased CPAP failure and need for MV in preterm infants.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
sunstar完成签到,获得积分10
刚刚
gyh应助樱桃园采纳,获得10
1秒前
失眠的冬易完成签到 ,获得积分10
1秒前
求索的舰菌完成签到,获得积分10
2秒前
碎碎发布了新的文献求助10
2秒前
雷大大完成签到,获得积分10
2秒前
SciGPT应助滴答滴答滴采纳,获得10
3秒前
3秒前
3秒前
4秒前
GPTea举报布丁求助涉嫌违规
4秒前
4秒前
4秒前
Hello应助wind采纳,获得10
5秒前
6秒前
美好的破茧完成签到,获得积分10
7秒前
研友_VZG7GZ应助朴实薯片采纳,获得10
7秒前
7秒前
lzjoe完成签到 ,获得积分10
7秒前
8秒前
lxaiczn发布了新的文献求助10
8秒前
CodeCraft应助沛宝无敌采纳,获得10
8秒前
灼灼朗朗完成签到,获得积分10
8秒前
9秒前
Orange应助ZD采纳,获得10
10秒前
10秒前
风中的断缘完成签到,获得积分10
10秒前
叮叮叮发布了新的文献求助10
10秒前
雷大大发布了新的文献求助10
11秒前
Mu丶tou发布了新的文献求助10
11秒前
lijingqi发布了新的文献求助10
12秒前
Languagesssss完成签到,获得积分10
12秒前
英姑应助过时的沛白采纳,获得10
13秒前
YangCK发布了新的文献求助20
14秒前
tt413dd完成签到,获得积分10
14秒前
15秒前
Georges-09发布了新的文献求助10
15秒前
科研通AI6.1应助chydlbb采纳,获得10
16秒前
mmr发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6019078
求助须知:如何正确求助?哪些是违规求助? 7611249
关于积分的说明 16160998
捐赠科研通 5166790
什么是DOI,文献DOI怎么找? 2765444
邀请新用户注册赠送积分活动 1747168
关于科研通互助平台的介绍 1635478